1.46 USD
↘ 0.07 (4.84%)PRE MARKET (AS OF 04:02 AM EDT)
ProQR Therapeutics N.V. Ordinary Shares
PRQRNASDAQ • USD
Market: OPEN
Open?$1.53
High?$1.53
Low?$1.46
Prev. Close?$1.53
Volume?1.0K
Avg. Volume?N/A
VWAP?$1.47
Bid / Ask
Bid?$1.25 × 100
Ask?$1.81 × 100
Spread?$0.56
Midpoint?$1.53
Valuation & Ratios
Market Cap?154.9M
Shares Out?105.4M
Float?80.2M
Float %?76.1%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
PRQR is currently priced at $1.46. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Jun 4, 2026.
News
Profile
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
Themes
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?84
Piotroski F-Score?0/9Weak
Altman Z-Score?-7.39Distress
Confidence?33%Very Low
Short InterestLow
Short % of Float?1.08%Low
Short Interest?865.7K
Days to Cover?1.8
Free Float80.2M
Avg Daily Volume496.0K
Settlement Date2026-05-15